NYSE:DLB - Dolby Laboratories Stock Price, Price Target & More

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories declared a quarterly dividend on Tuesday, April 24th. Investors of record on Monday, May 7th will be paid a dividend of $0.16 per share on Wednesday, May 16th. This represents a $0.64 annualized dividend and a yield of 1.02%. The ex-dividend date is Friday, May 4th. View Dolby Laboratories' Dividend History.

Dolby Laboratories declared that its board has authorized a share buyback program on Sunday, April 9th 2017, which permits the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) announced its earnings results on Tuesday, April, 24th. The electronics maker reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.14. The electronics maker earned $301.36 million during the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. The company's revenue for the quarter was up 12.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.63 earnings per share. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories issued an update on its third quarter earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $0.78-0.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.97. The company issued revenue guidance of $310-320 million, compared to the consensus revenue estimate of $330.43 million.

5 analysts have issued twelve-month price objectives for Dolby Laboratories' stock. Their forecasts range from $52.00 to $78.00. On average, they anticipate Dolby Laboratories' share price to reach $65.20 in the next year. View Analyst Ratings for Dolby Laboratories.

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Quarterhill (QTRH), Digital Turbine (APPS), Liberty Tax Service (TAX), The Joint (JYNT), MGT Capital Investments (MGTI), Finjan (FNJN), Copytele (ITUS), XCel Brands (XELB), Marathon Patent Group (MARA), Research Frontiers (REFR) and ARC Group (ARCK).

Press coverage about DLB stock has been trending somewhat positive on Monday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dolby Laboratories earned a news impact score of 0.14 on Accern's scale. They also gave news coverage about the electronics maker an impact score of 45.57 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Dolby Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.87%), American Century Companies Inc. (1.44%), Allianz Asset Management GmbH (1.12%), Thrivent Financial for Lutherans (0.92%), Fiera Capital Corp (0.83%) and OppenheimerFunds Inc. (0.77%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Schroder Investment Management Group, American Century Companies Inc., JPMorgan Chase & Co., OppenheimerFunds Inc., UBS Group AG, BlackRock Inc. and Russell Investments Group Ltd.. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, DekaBank Deutsche Girozentrale, Columbus Circle Investors, Fiera Capital Corp, Blair William & Co. IL, Wells Fargo & Company MN, Schwab Charles Investment Management Inc. and Guggenheim Capital LLC. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $62.58.

Dolby Laboratories has a market capitalization of $6.50 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]